Defence Therapeutics Company Description

Defence Therapeutics Inc. engages in development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.

The company focuses on development of vaccine for infectious disease and virus utilizing the ACCUMTM platform for drug delivery and effective treatments.

The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020.

The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Defence Therapeutics Inc.

Country	Canada
Founded	2017
Industry	Biotechnology
Sector	Healthcare
CEO	Kwin Grauer

Contact Details

Address: 1680 – 200 Burrard Street Vancouver, British Columbia V6C 3L6 Canada
Phone	514 947 2272
Website	defencetherapeutics.com

Stock Details

Ticker Symbol	DTC
Exchange	Canadian Securities Exchange
Fiscal Year	July - June
Reporting Currency	CAD
ISIN Number	CA24463V1013
SIC Code	2836

Key Executives

Name	Position
Kwin Grauer	Chief Executive Officer
Patrick Meagher	Chief Financial Officer